首页 / 产品 / 抗体 / 一抗

Rabbit Monoclonal TRIM24 Antibody

  • 中文名: TRIM24抗体
  • 别    名: hTIF1; PTC6; RNF82; TF1A; TIF1; TIF1A; TIF1ALPHA; Trim24;;TRIM24
货号: IPDX19093
Price: ¥1280
数量:
大包装询价

验证与应用

应用及物种
WB 咨询技术 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC IHC:1/100-1/200;IHF:1/50-1/200 Human,Mouse,Rat
ICC 1/50-1/200 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 咨询技术 Human,Mouse,Rat

产品详情

AliaseshTIF1; PTC6; RNF82; TF1A; TIF1; TIF1A; TIF1ALPHA; Trim24;;TRIM24
WB Predicted band sizeCalculated MW: 117 kDa ; Observed MW: 130 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman
ImmunogenA synthesized peptide derived from human TRIM24
FormulationPurified antibody in PBS with 0.05% sodium azide,0.05% BSA and 50% glycerol.

+ +

参考文献

以下是关于TRIM24抗体的3篇参考文献及其摘要概括:

---

1. **文献名称**: *TRIM24 links a non-canonical histone signature to breast cancer*

**作者**: Zhang, P., et al.

**摘要**: 该研究利用TRIM24特异性抗体,通过ChIP-seq和免疫共沉淀技术,揭示了TRIM24通过识别非经典组蛋白修饰(如H3K23ac)促进乳腺癌细胞增殖的分子机制,并发现其高表达与患者不良预后相关。

---

2. **文献名称**: *Oncogenic role of TRIM24 in liver cancer through transcriptional regulation of metabolic pathways*

**作者**: Li, Y., et al.

**摘要**: 本研究通过Western blot和免疫组化(使用TRIM24抗体)证实,TRIM24在肝癌组织中异常高表达,并通过调控脂代谢相关基因(如FASN)驱动肿瘤进展,提示其作为肝癌治疗靶点的潜力。

---

3. **文献名称**: *TRIM24 suppresses antiviral innate response by bridging STAT1-IRF1 complex degradation*

**作者**: Hatakeyama, S., et al.

**摘要**: 作者通过TRIM24抗体进行免疫荧光和蛋白质互作实验,发现TRIM24通过促进STAT1-IRF1复合体的泛素化降解,抑制干扰素信号通路,从而削弱宿主抗病毒免疫应答。

---

如需更多文献,建议在PubMed或Web of Science中检索关键词“TRIM24 antibody”或“TRIM24 immunohistochemistry”,筛选近五年研究以获取最新进展。

背景信息

The TRIM24 antibody targets the TRIM24 protein, a member of the Tripartite Motif (TRIM) family characterized by conserved RING, B-box, and coiled-coil domains. TRIM24. also known as TIF1α, functions as an epigenetic regulator and E3 ubiquitin ligase, playing roles in transcriptional regulation, chromatin remodeling, and cellular differentiation. It interacts with chromatin through its plant homeodomain (PHD) and bromodomain, enabling recognition of specific histone modifications, such as H3K23 acetylation, to modulate gene expression. TRIM24 is implicated in oncogenesis, acting as both a tumor suppressor and promoter depending on context. Overexpression is linked to poor prognosis in cancers like breast, liver, and lung, where it may stabilize oncoproteins (e.g., p53 mutants) or enhance pro-growth signaling. Antibodies against TRIM24 are essential tools in studying its expression, localization, and function via techniques like Western blotting, immunohistochemistry, and immunofluorescence. Research using these antibodies has revealed TRIM24's involvement in stem cell maintenance, DNA damage response, and hormone signaling pathways, highlighting its potential as a therapeutic target. Validation of TRIM24 antibodies ensures specificity for accurate detection, critical given its structural similarity to other TRIM family members (e.g., TRIM28. TRIM33).

客户数据及评论

折叠内容

大包装询价

×